Evidence map›Paper›PMID 42068265›Full record

ArticleACS applied materials & interfaces2026

Image-Guided In Vivo Tracking of Splenocyte Dynamics Using Superparamagnetic Iron Oxide-Based Nanoparticles in a Rodent Model.

Archana Mishra, Dominic Karl M Bolinas, Poonam Yadav, Allan John R Barcena, Santosh K Mandal, Kitz Paul D Marco, Kaitlin A Ricks, Gino M Canlas, Rahul A Sheth, Marites P Melancon

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Archana MishraDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Dominic Karl M BolinasDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.ORCID 0000-0002-6762-1149
Poonam YadavDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Allan John R BarcenaDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.ORCID 0000-0001-5067-0334
Santosh K MandalDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Kitz Paul D MarcoDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.ORCID 0009-0004-0966-6201
Kaitlin A RicksDepartment of Chemistry, Lamar University, Beaumont, Texas 77710, United States.
Gino M CanlasDepartment of Chemistry, Lamar University, Beaumont, Texas 77710, United States.
Rahul A ShethDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.
Marites P MelanconDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, United States.ORCID 0000-0002-7447-0705

Funding

Biodegradable Radiopaque Polymeric Scaffolds Loaded with Mesenchymal Stem Cells for Image-Guided Arteriovenous Fistula Maturation and Long-Term PatencyR01HL159960 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MELANCON, MARITES PASUELO · 2022 to 2025
$1.6M
Drug-loaded degradable biopolymeric scaffolds for augmenting preoperative liver growthR01CA307595 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Marites Pasuelo Melancon · 2026 to 2026
$680k
NCI NIH HHS R01 CA307595NHLBI NIH HHS R01 HL159960
6 · The paper itself

Abstract

The spleen serves as a critical reservoir of immune cells that play a key role in chronic inflammation and malignancy. While migration of immune cells from the spleen to the tumor immune microenvironment has been described, the dynamics of this process are poorly understood. Tracking the in vivo dynamics could provide valuable insights for understanding tumor immune biology, as well as potentially improving immunotherapy-based treatment regimens. In this study, splenocytes were labeled with superparamagnetic iron oxide (SPIO) nanoparticles conjugated with protamine-indocyanine green (SPIOpICG) for noninvasive, biocompatible, and real-time tracking. Transmission electron microscopy confirmed spherical SPIO and SPIOpICG with average sizes of 9.3 ± 3.1 and 12.7 ± 2.7 nm, respectively. SPIO exhibited a hydrodynamic volume of 110.37 ± 10.56 nm with a polydispersity index (PDI) of 0.356 ± 0.075, whereas SPIOpICG showed a hydrodynamic volume of 1078.48 ± 24.23 nm with a PDI of 0.399 ± 0.540. Ex vivo labeling of splenocytes demonstrated high cell viability (96.2 ± 2.8%) and uptake efficiency (94.3 ± 2.1%) after 24 h, confirming the nanoconjugate biocompatibility. Tumor-bearing Buffalo rat models received intravenous injections of free SPIOpICG or SPIOpICG-splenocytes. MRI performed before and 24 h postinjection revealed a significant reduction in T

Indexed as

Cell TrackingMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesSpleenAnimalsFerric CompoundsMagnetic Resonance ImagingRatsFerric Compoundsferric oxideMagnetite Nanoparticlescancerin vivo trackingmagnetic resonance imaging (MRI)splenocytessuperparamagnetic iron oxide (SPIO) nanoparticlestargeted delivery

Identifiers

PMID42068265
PMCPMC13306710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.